Advertisement
Research Article Free access | 10.1172/JCI115808
Institut National de la Santé et de la Recherche Médicale Unité 311, Centre Régional de Transfusion Sanguine, Strasbourg, France.
Find articles by Lanza, F. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 311, Centre Régional de Transfusion Sanguine, Strasbourg, France.
Find articles by Stierlé, A. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 311, Centre Régional de Transfusion Sanguine, Strasbourg, France.
Find articles by Fournier, D. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 311, Centre Régional de Transfusion Sanguine, Strasbourg, France.
Find articles by Morales, M. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 311, Centre Régional de Transfusion Sanguine, Strasbourg, France.
Find articles by André, G. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 311, Centre Régional de Transfusion Sanguine, Strasbourg, France.
Find articles by Nurden, A. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Médicale Unité 311, Centre Régional de Transfusion Sanguine, Strasbourg, France.
Find articles by Cazenave, J. in: JCI | PubMed | Google Scholar
Published June 1, 1992 - More info
We describe a new variant of Glanzmann's thrombasthenia (variant Strasbourg I). The patient (M.S.) showed an absence of platelet aggregation to ADP, thrombin, and collagen, and a decreased clot retraction. Platelet fibrinogen was approximately 20% of normal levels. ADP-stimulated platelets bound markedly reduced amounts of soluble fibrinogen and platelet adhesion to surface-bound fibrinogen was defective. Normal to subnormal amounts of glycoprotein (GP) IIb-IIIa (alpha IIb beta 3) complexes, the platelet fibrinogen receptor, were revealed by SDS-PAGE, crossed immunoelectrophoresis, and antibody binding. However, the complexes were unusually sensitive to dissociation with EDTA at room temperature. Furthermore, flow cytometry showed that the platelets failed to bind the activation-dependent monoclonal antibody, PAC-1, after stimulation. In contrast, an RGDS-containing peptide induced significant binding of the anti-ligand-induced binding site antibody, D3GP3, suggesting the presence of a functional RGD binding domain on the patient's GPIIb-IIIa complex. Sequence analysis was performed after polymerase chain reaction amplification of selected patient's GPIIIa exons, and of the patient's platelet GPIIb and GPIIIa mRNAs. A point mutation (C to T) was localized in exon D (iv) of GPIIIa that resulted in an 214Arg to 214Trp amino acid substitution. The defect has been inherited from the parents who are heterozygous for the same mutation. This substitution points to an essential amino acid in a region of GPIIIa involved in the binding of fibrinogen and influencing the Ca(2+)-dependent stability of the GPIIb-IIIa complex.
Images.